Perception and Representation of Internal Body in Anorexia Nervosa

Anorexia Nervosa Clinical Trial

— PERCEPCOR  

Official title:

Perception and Representation of Internal Body in Anorexia Nervosa

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03988218
• Other study ID #: percepcor
• Status: Completed
• Phase: N/A
• Start date: January 11, 2018
• Est. completion date: July 7, 2021

Study information

• Verified date: July 2021
• Source: Centre Hospitalier Esquirol
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study focuses on representations of the interior of the body and interoceptive awareness in women with anorexia nervosa in comparison with women without eating disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: July 7, 2021
• Est. primary completion date: March 25, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 14 Years and older

Eligibility

Inclusion Criteria:

• Anorexia Nervosa according to DSM-5

• aged above than 14

• BMI between 14 and 18.5 for adults or less than the reference age by age for minors

Exclusion Criteria:

• Unable to understand the tests, poor understanding of the French language

• Mental retardation

• Severe psychiatric comorbidity (bipolar disorder, schizophrenia)

• Lesion or pathology of the upper limbs

• Pregnancy

• Absence of social protection

• Hospitalization under duress

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa

Intervention

Behavioral:
• perceptive tests
many tests are realized: a drawing of the interior of the body a heartbeat detection test an ischemia induction test many scales: Eating Attitude Test; Body Awareness Questionnaire; Body Shape Questionnaire; Hospital Anxiety and Depression; Questionnaire de Satisfaction Corporelle et de Perception Globale de Soi

Locations

Country	Name	City	State
France	Centre Hospitalier Esquirol	Limoges

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Esquirol

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	drawing	Number and nature of organs drawn	At inclusion
Secondary	IAI	interoceptive awareness index	At inclusion
Secondary	Time	time to obtain a score of 3 on the analogue visual scale at the ischemia induction test	At inclusion